About Jisenkai Nanko Psychiatric Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sunovion
2
AstraZeneca
1
Mitsubishi Tanabe Pharma Corporation
1
Otsuka Pharmaceutical Co., Ltd.
1
Clinical Trials at Jisenkai Nanko Psychiatric Institute
During the past decade, Jisenkai Nanko Psychiatric Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
2016-07-01
2018-09-28
Terminated
1,722
Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
2017-06-21
2020-09-29
Completed
256
A Study of Brexpiprazole in Patients With Major Depressive Disorder
2018-07-30
2022-07-04
Completed
740
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
2021-12-21
2025-05-31
Recruiting
522
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).
2022-03-17
2029-05-31
Enrolling by invitation
355
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Jisenkai Nanko Psychiatric Institute"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Jisenkai Nanko Psychiatric Institute
According to Clinical.Site data, the most researched conditions in "Jisenkai Nanko Psychiatric Institute" are
"Depressive Episodes, Bipolar I Depression" (2 trials), "Alzheimer's Disease" (1 trials), "Major Depressive Disorder" (1 trials) and "Tardive Dyskinesia" (1 trials). Many other conditions were trialed in "Jisenkai Nanko Psychiatric Institute" in a lesser frequency.
Clinical Trials Intervention Types at Jisenkai Nanko Psychiatric Institute
Most popular intervention types in "Jisenkai Nanko Psychiatric Institute" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Brexpiprazole" (1 trials), "Lanabecestat" (1 trials), "MT-5199" (1 trials) and "SEP-4199 CR" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Jisenkai Nanko Psychiatric Institute
The vast majority of trials in "Jisenkai Nanko Psychiatric Institute" are
5 trials for "All" genders.
Clinical Trials Status at Jisenkai Nanko Psychiatric Institute
Currently, there are NaN active trials in "Jisenkai Nanko Psychiatric Institute".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 2 completed trials in Jisenkai Nanko Psychiatric Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Jisenkai Nanko Psychiatric Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".